Upfront autologous stem cell transplantation (ASCT) Vs carfilzomib-cyclophosphamide-dexamethasone (KCD) consolidation in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM): results of the cardamon study according to cytogenetic risk
dc.contributor.author | Yong, K. | |
dc.contributor.author | Wilson, W. | |
dc.contributor.author | Camilleri, M. | |
dc.contributor.author | Ramasamy, K. | |
dc.contributor.author | Streetly, M. | |
dc.contributor.author | Sive, J. | |
dc.contributor.author | Bygrave, C. A. | |
dc.contributor.author | Chapman, M. | |
dc.contributor.author | de Tute, R. M. | |
dc.contributor.author | Chavda, S. J. | |
dc.contributor.author | Phillips, Elizabeth H | |
dc.contributor.author | Cuadrado, M. D. M. | |
dc.contributor.author | Pang, G. | |
dc.contributor.author | Jenner, R. | |
dc.contributor.author | Dadaga, T. | |
dc.contributor.author | Kamora, S. | |
dc.contributor.author | Cavenagh, J. | |
dc.contributor.author | Clifton-Hadley, L. | |
dc.contributor.author | Owen, R. G. | |
dc.contributor.author | Popat, R. | |
dc.date.accessioned | 2022-10-19T13:13:22Z | |
dc.date.available | 2022-10-19T13:13:22Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Yong K, Wilson W, Camilleri M, Ramasamy K, Streetly M, Sive J, et al. Upfront Autologous Stem Cell Transplantation (ASCT) Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Consolidation in Transplant-Eligible, Newly Diagnosed (NDTE) Multiple Myeloma (MM): Results of the Cardamon Study According to Cytogenetic Risk. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413903204. | en |
dc.identifier.doi | 10.1182/blood-2021-147771 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625650 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1182/blood-2021-147771 | en |
dc.title | Upfront autologous stem cell transplantation (ASCT) Vs carfilzomib-cyclophosphamide-dexamethasone (KCD) consolidation in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM): results of the cardamon study according to cytogenetic risk | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Cancer Institute, Department of Haematology, University College London, London, United Kingdom | en |
dc.identifier.journal | Blood | en |
dc.description.note | en] |